This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Grigg A, Kimber R, Szer J . Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation. Leukemia ; 17: 1916–1917.
Tedeschi A, Cairoli R, Marenco P, Nosari A, Tresoldi E, Di Bona E et al. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation. Leukemia 2002; 16: 2455–2456.
Jurcic JC . Antibody therapy for residual disease in acute myelogenous leukemia. Clin Rev Oncol Hematol 2001; 38: 37–45.
Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ et al. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 1999; 94: 2230–2235.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tedeschi, A., Montillo, M. & Morra, E. Reply to A Grigg et al. Leukemia 17, 1918 (2003). https://doi.org/10.1038/sj.leu.2403051
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403051